RESUMO
Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.
Assuntos
Delirium por Abstinência Alcoólica/diagnóstico , Etanol/efeitos adversos , Delirium por Abstinência Alcoólica/tratamento farmacológico , Delirium por Abstinência Alcoólica/fisiopatologia , Delirium por Abstinência Alcoólica/terapia , Convulsões por Abstinência de Álcool/tratamento farmacológico , Convulsões por Abstinência de Álcool/fisiopatologia , Alcoolismo/sangue , Alcoolismo/complicações , Anticonvulsivantes/uso terapêutico , Antipsicóticos/efeitos adversos , Antipsicóticos/uso terapêutico , Sistema Nervoso Autônomo/fisiopatologia , Benzodiazepinas/administração & dosagem , Benzodiazepinas/uso terapêutico , Terapia Combinada , Aconselhamento , Diagnóstico Tardio , Quimioterapia Combinada , Emergências , Etanol/sangue , Humanos , Excitação Neurológica , Cuidados Paliativos , Índice de Gravidade de Doença , Avaliação de Sintomas , Tiamina/uso terapêuticoRESUMO
Pharmacological treatment of alcohol use disorder represents an essential core of the therapeutic project in a multidisciplinary approach. While non-drug treatment is evolving, from a medical perspective few pharmacotherapies are available; in particular acamprosate, naltrexone and more recently nalmefene among anticraving drugs, disulfiram as an antidipsotropic medication. New studies are focusing on off-label drugs. Moreover, scientific evidence has to support any therapeutic indication which should be tailored on patient needs and comorbidity by considering the individual bio-psycho-social profile. Follow-up is essential in order to assess patient compliance to treatment and monitoring outcomes.
Assuntos
Dissuasores de Álcool/uso terapêutico , Alcoolismo/tratamento farmacológico , Acamprosato/uso terapêutico , Baclofeno/uso terapêutico , Dissulfiram/uso terapêutico , Avaliação de Medicamentos , Humanos , Naltrexona/análogos & derivados , Naltrexona/uso terapêutico , Uso Off-Label , Olanzapina/uso terapêutico , Ondansetron/uso terapêutico , Sertralina/uso terapêutico , Oxibato de Sódio/uso terapêutico , Topiramato/uso terapêutico , Vareniclina/uso terapêuticoRESUMO
Alcohol use disorder (AUD) is one of the most common psychiatric disease in the general population, characterized by having a pattern of excessive drinking despite the negative effects of alcohol on the individual's work, medical, legal, educational, and/or social life. Currently, the bio-psycho-social model describes properly AUD as a multidimensional phenomenon including biological, psychological, and socio-cultural variables affecting the nature, maintenance, and expression of the disorder. The AUD diagnostic process is crucial since the treatment success depends heavily on the accuracy and the adequacy of the diagnosis. The diagnosis is based on a comprehensive assessment of the patient's characteristics and uses interviews and psychometric instruments for collecting information. This paper will provide insights into the most important psychological dimensions of AUD and on the best psychometric instruments for proposing AUD diagnosis.